z-logo
open-access-imgOpen Access
Faecal microbiota transplants: Why do we not consider them as Advanced Therapy Medicinal Products?
Author(s) -
Verbeke Frederick,
De Spiegeleer Bart
Publication year - 2021
Publication title -
ueg journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.667
H-Index - 35
eISSN - 2050-6414
pISSN - 2050-6406
DOI - 10.1002/ueg2.12066
Subject(s) - directive , medicine , european union , transplantation , good manufacturing practice , fecal bacteriotherapy , personalized medicine , business , microbiology and biotechnology , bioinformatics , international trade , regulatory affairs , surgery , biology , clostridium difficile , antibiotics , computer science , programming language

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom